menu
    • menu

    Company profile for Sareum

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate. Sareum's most advanced development programme (Chk1) was developed in collaboration with the Institute of Cancer Research and the CRT Pioneer Fund. It is currently completing the secon...
    Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate. Sareum's most advanced development programme (Chk1) was developed in collaboration with the Institute of Cancer Research and the CRT Pioneer Fund. It is currently completing the second of two Phase 2 clinical trials, being conducted by licence partner Sierra Oncology, with a further two trials planned.\

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sareumunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Unit 2A, Langford Arch London Road, Pampisford Cambridge CB22 3FX
    Telephone
    Telephone
    +44 (0) 1223 497700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.sareum.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sareum-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Sareumplc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sareum receives approval to commence SDC-1801 trial in Australia
    Sareum receives approval to commence SDC-1801 trial in Australia

    05 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/sareum-approval-sdc-1801-australia/

    CLINICAL TRIALS ARENA
    05 May 2023
    Share Share
    Sareum submits Trial Authorisation appln to MHRA for development of SDC-1801
    Sareum submits Trial Authorisation appln to MHRA for development of SDC-1801

    28 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/28/2487660/0/en/Sareum-submits-Clinical-Trial-Authorisation-application-to-UK-MHRA-for-development-of-TYK2-JAK1-inhibitor-SDC-1801-and-provides-an-Operational-Update.html

    GLOBENEWSWIRE
    28 Jul 2022
    Share Share
    Sareum to Present at BioTrinity 2022 Conference
    Sareum to Present at BioTrinity 2022 Conference

    26 Apr 2022

    // PRESS RELEASE

    http://www.sareum.com/news/press-releases-and-news/2022/sareum-present-biotrinity-2022-conference/

    PRESS RELEASE
    26 Apr 2022
    Share Share
    Sareum notes proposed acquisition of Sierra Oncology by GSK
    Sareum notes proposed acquisition of Sierra Oncology by GSK

    13 Apr 2022

    // PRESS RELEASE

    http://www.sareum.com/news/press-releases-and-news/2022/sareum-notes-proposed-acquisition-sierra-oncology-gsk/

    PRESS RELEASE
    13 Apr 2022
    Share Share
    European Patent Granted for Sareum’s SDC-1802 for T-ALL
    European Patent Granted for Sareum’s SDC-1802 for T-ALL

    11 Apr 2022

    // PRESS RELEASE

    http://www.sareum.com/news/press-releases-and-news/2022/european-patent-granted-sareums-sdc-1802/

    PRESS RELEASE
    11 Apr 2022
    Share Share
    Subscription to raise approximately £1.63 million to progress TYK2/JAK1
    Subscription to raise approximately £1.63 million to progress TYK2/JAK1

    17 Dec 2021

    // SAREUM

    http://www.sareum.com/news/press-releases-and-news/2021/subscription-raise-163m-progress-sdc-1801/

    SAREUM
    17 Dec 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search